New Law Allows Physicians to Help Patients Receive Their Medical News – Good or Bad
Aug.19, 2025 A new law effective Sept. 1 will protect Texas patients from the confusion of receiving difficult-to-decipher health information in their inbox with no explanation, thanks to the efforts of Texas physicians. Instead, doctors will have time to review the patient’s test results and call them to reveal the news – good or bad – […]
Doublet Shows Activity in Rare, Aggressive Kidney Cancer
There is currently no effective therapy for patients with advanced HLRCC-associated papillary renal cell carcinoma. Treatment with bevacizumab and erlotinib resulted in a confirmed response of 72% in patients with hereditary papillary renal cell carcinoma. The combination was approximately half as effective in patients with sporadic papillary renal cell carcinoma. Bevacizumab (Avastin) combined with erlotinib […]
Topical Gel Soothes Skin Rash for CRC Patients on EGFR Inhibitors
The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients with advanced colorectal cancer who were treated with an epidermal growth factor receptor (EGFR)-targeted drug, a randomized phase II trial showed. The 39 patients randomly assigned to receive a high-dose 0.1% formulation of LUT014 gel were twice […]
Unprecedented Response Rates in Non-Responsive, Non-Muscle Invasive Bladder Cancer
LAS VEGAS — Patients with high-risk, treatment-unresponsive non-muscle invasive bladder cancer (NMIBC) had an unprecedented response rate and disease-free survival (DFS) with an investigational intravesical treatment system, data from an ongoing trial showed. Complete responses (CR) occurred in 82.4% of 85 patients treated with TAR-200, a system that delivers gemcitabine directly into the bladder. The […]